Literature DB >> 16229223

Integration of microscopy and serodiagnostic tests to screen for active tuberculosis.

G V Kanaujia1, P K Lam, S Perry, P N Brusasca, A Catanzaro, M L Gennaro.   

Abstract

SETTING: University of California San Diego Medical Center, USA.
OBJECTIVE: To create a simple screening strategy for tuberculosis (TB) that includes antibody detection assays to improve the accuracy of microscopic examination of sputum for acid-fast bacilli (AFB smear).
METHODS: Serum samples were obtained from 190 patients suspected of having active TB. TB diagnosis was established by Mycobacterium tuberculosis culture. HIV status was determined by commercial serologic tests. IgG antibody levels were measured by ELISA using purified M. tuberculosis antigens. Data from 130 randomly selected patients were used to develop a screening strategy; data from the remaining 60 patients were used for validation.
RESULTS: AFB smear had 70% sensitivity and 88% specificity. In algorithms integrating single or multi-antigen ELISA with AFB smear and HIV results, the sensitivity improved over each test alone. The algorithm that included a four-antigen ELISA (38 kDa antigen, lipoarabinomannan, MPT-64 and glutamine synthase) had a sensitivity of 93% and a specificity of 76%. Compared to AFB smear, the sensitivity of the algorithm was significantly higher, while the specificity was not statistically different.
CONCLUSION: This study demonstrates that a screening strategy can be created by integrating multi-antigen ELISA with AFB smear and HIV testing.

Entities:  

Mesh:

Year:  2005        PMID: 16229223

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV.

Authors:  Laura Savolainen; Anu Kantele; Bettina Sandboge; Marita Sirén; Heikki Valleala; Riitta Tuompo; Liana Pusa; Riitta Erkinjuntti-Pekkanen; Aija Knuuttila; Cheng-Lung Ku; Chih-Yu Chi; Tuula Vasankari; Tamara Tuuminen
Journal:  Clin Vaccine Immunol       Date:  2013-07-03

2.  The incidence and clinical implication of sputum with positive acid-fast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea.

Authors:  Jae Seok Lee; Eui-Chong Kim; Sei Ick Joo; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

3.  Direct microscopy versus sputum cytology analysis and bleach sedimentation for diagnosis of tuberculosis: a prospective diagnostic study.

Authors:  Pamela Hepple; Pascal Nguele; Jane Greig; Maryline Bonnet; Vinciane Sizaire
Journal:  BMC Infect Dis       Date:  2010-09-21       Impact factor: 3.090

4.  Diagnostic performance and problem analysis of commercial tuberculosis antibody detection kits in China.

Authors:  Xue-Juan Bai; You-Rong Yang; Jian-Qin Liang; Hui-Ru An; Jie Wang; Yan-Bo Ling; Zhong-Yuan Wang; Xue-Qiong Wu
Journal:  Mil Med Res       Date:  2018-03-22

Review 5.  A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment.

Authors:  Chunling Lu; Qing Liu; Aartik Sarma; Christopher Fitzpatrick; Dennis Falzon; Carole D Mitnick
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

6.  IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis.

Authors:  Xiaoyan Feng; Xiqin Yang; Bingshui Xiu; Shuang Qie; Zhenhua Dai; Kun Chen; Ping Zhao; Li Zhang; Russell A Nicholson; Guohua Wang; Xiaoguo Song; Heqiu Zhang
Journal:  BMC Infect Dis       Date:  2014-06-17       Impact factor: 3.090

7.  Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis.

Authors:  Parvaneh Baghaei; Payam Tabarsi; Hojat Sabour; Shokoufeh Dehghani; Majid Marjani; Masoud Shamaei; Ali Jabbari; Majid Valiollahpour Amiri; Ali Akbar Velayati
Journal:  Tanaffos       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.